治疗婴儿血瘤的普拉诺洛尔的负担:一个混合方法研究研究
Cathal O'Connor1,2,3, Michelle Murphy1,2
1Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Pediatric dermatology
|May 22, 2024
概括
使用普拉诺洛尔的婴儿血管瘤的护理人员的治疗负担非常低. 通过优化监测和管理指导,可以进一步降低负担.
科学领域:
- 儿科皮肤学 儿科皮肤学
- 药理学 药理学是指药理学的学科.
- 患者报告的结果.
背景情况:
- 婴儿血管瘤 (IH) 是婴儿常见的血管瘤.
- 甲醇是IH的第一线治疗方法,但其治疗负担尚未评估.
- 了解治疗负担对于优化患者和护理人员管理至关重要.
研究的目的:
- 探索和评估与婴儿血瘤的propranolol治疗相关的治疗负担.
- 确定有助于增加护理人员治疗负担的特定领域.
主要方法:
- 使用了经过修改和验证的治疗负担问卷.
- 与护理人员进行了一对一的半结构化采访.
- 包括80名护理婴儿的护理人员,这些婴儿接受了用于IH的propranolol治疗.
主要成果:
- 整体治疗负担得分非常低 (10分之1.2分).
- 主题分析确定了关键主题:管理,监测,财务方面以及相关异常.
- 护理人员报告的与IH的propranolol相关的负担很小.
结论:
- 治疗婴儿血瘤的普罗普拉诺洛尔对护理人员来说是一个非常低的负担.
- 潜在的改善包括基于年龄的低血糖风险分层,优化剂量时间和减少监测频率.
相关概念视频
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
728
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
728
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
434
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
434